ErSO update from the lead researcher - SHARE Metastatic ...

SHARE Metastatic Breast Cancer

6,770 members8,366 posts

ErSO update from the lead researcher

Cureforever profile image
6 Replies

Please find another update from the lead researcher Dr. Shapiro

Written by
Cureforever profile image
Cureforever
To view profiles and participate in discussions please or .
6 Replies
Ycats277 profile image
Ycats277

Awesome 👏🏼

Lulu4545 profile image
Lulu4545

Hi Marina,What's going on then? Can we still hope a trial will come out before the end of the year?

Lovexxx

Lucie

Cureforever profile image
Cureforever in reply to Lulu4545

Hi Lucie,No trials are announced. We still have hope that the Systems Solution company that owns the license will find a company that will develop the ErSO drug out of the compound. But it might take a long time. No one knows. The point that the researchers raised in their emails that it is still there

Best,

Marina

Cureforever profile image
Cureforever in reply to Lulu4545

Sorry Systems Oncology owns the license now. We contacted them but did not get a reply yet. Best,

Marina

Bettybuckets profile image
Bettybuckets

Thanks for taking the time to write to Dr Shapiro and us. Fingers and toes crossed!

Cureforever profile image
Cureforever in reply to Bettybuckets

We still have hope

Not what you're looking for?

You may also like...

ErSO update from the main researcher DrShapiro

Hi wonderful people, We just received this update. There is still hope Best, Marina

ErSO update from the researchers

Hi wonderful people, Today the member of our group on Facebook received a very promising email from...

ErSO update

Hi wonderful people, Many of you asked to post the update. Here is the update posted on Facebook in...

Sad update about ErSO

Hi friends, I am sorry to be the messenger of a disappointing news. I am so upset Here is the...

Latest update about ErSO from the Facebook group posted by Danny Goss

We just thought we would post a current summary of the status of ErSO as we know it. It can be...